US President Donald Trump has announced steep tariffs on imported generic medicines. The move is designed to encourage pharmaceutical manufacturers to relocate production to the United States. Trump said generic medicines would remain tariff-free for two years from 1 August 2026. A 100% tariff would then apply for one year from August 2028. This would increase to 200% from August…
Tag: US Healthcare
-
US Prescription Drug Spending to Top $560bn in 2026
US prescription drug spending will top $560 billion in 2026, according to current projections. This would represent an 8.2% increase from the previous year. Growing demand for obesity and diabetes treatments is partly driving this rise. These include a new generation of GLP-1 medicines. Projections show prescription medicines outpacing all other major categories of healthcare spending in the US. Their…
-
Employer Health Insurance Costs To Rise For US Workers In 2027
US workers are likely to pay more for employer-sponsored health insurance in 2027. Large companies are preparing to pass more healthcare costs on to staff. This follows another year of rising medical inflation and prescription drug costs. A Mercer survey of companies with at least 500 employees found that two-thirds of large employers expect to raise monthly health insurance premiums…
-
Employer-Sponsored Health Insurance Costs Rising Sharply
A salaried job with health benefits has long been the gold standard of US employment. That assumption is now under serious pressure. Sharply rising premiums are prompting young, healthy workers to opt out of company health plans. Some are going without cover entirely. Others are turning to cheaper alternatives such as medical cost-sharing cooperatives. The trend is a growing concern…
-
Weight-Loss Drug Costs Fuel US Employer Healthcare Cuts
More than half of large employers in the United States are planning to reduce their healthcare benefits in 2026. This decision comes as the skyrocketing cost of new weight-loss and specialty medicines puts unprecedented pressure on budgets. The soaring costs of weight-loss drugs are a key concern, according to a new survey. The report, released on Wednesday by consulting firm…